Advertisement
Screener

AMNEAL PHARMACEUTICALS, INC. (AMRX) Debt / Equity

AMNEAL PHARMACEUTICALS, INC. (AMRX) Debt / Equity

  • 2026-06-30: Debt/Equity Ratio 77.83.
  • 2026-03-31: Debt/Equity Ratio -56.63.
  • 2025-12-31: Debt/Equity Ratio -36.33.
  • 2025-09-30: Debt/Equity Ratio -23.51.

Complete source-backed debt/equity ratio history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity Ratio
2026-06-3077.83
2026-03-31-56.63
2025-12-31-36.33
2025-09-30-23.51
2025-06-30-19.42
2025-03-31-16.6
2024-12-31-21.84
2024-09-30-25.63
2024-06-30-41.81
2024-03-31-37.84
2023-12-31122.35
2023-09-307.77
2023-06-308.11
2023-03-318.8
2022-12-318.79
2022-09-308.87
2022-06-309.46
2022-03-316.91
2021-12-317.52
2021-09-307.75
2021-06-307.95
2021-03-318.54
2020-12-319.17
2020-09-309.26
2020-06-309.13
2020-03-318.8
2019-12-3111.34
2018-12-315.25

Annual Debt/Equity Ratio

DateDebt/Equity Ratio
2025-12-31-36.33
2024-12-31-21.84
2023-12-31122.35
2022-12-318.79
2021-12-317.52
2020-12-319.17
2019-12-3111.34
2018-12-315.25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Liquidia Corp (LQDA)United States$6.347B51.23
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
Alkermes plc. (ALKS)$6.844B132.74
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Cogent Biosciences, Inc. (COGT)United States$5.450B-17.61
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Gossamer Bio, Inc. (GOSS)United States$5.355B-0.65
PTC THERAPEUTICS, INC. (PTCT)United States$5.199B-177.07